Login / Signup

Nutritional status indicators predict tolerability to adjuvant chemotherapy in patients with stage II/III rectal cancer undergoing neoadjuvant chemoradiotherapy.

Shinya AbeHiroaki NozawaKazuhito SasakiKoji MuronoShigenobu EmotoYuichiro YokoyamaHiroyuki MatsuzakiYuzo NagaiTakahide ShinagawaHirofumi SonodaSoichiro Ishihara
Published in: Digestion (2024)
The discontinuation of AC was related to poor RFS in patients with LARC undergoing preoperative CRT. Furthermore, a low PNI value was identified as a risk factor for a shorter duration of AC.
Keyphrases
  • rectal cancer
  • locally advanced
  • patients undergoing
  • open label
  • squamous cell carcinoma
  • radiation therapy
  • cardiac resynchronization therapy
  • heart failure
  • placebo controlled
  • left ventricular
  • drug induced